Impact of the COVID-19 pandemic on the routine measurement of cardiometabolic disease risk factors in primary care in England
The COVID-19 pandemic reduced incident prescriptions for preventative cardiovascular disease (CVD) medicines, which could in part be related to reduced risk factor measurements. We examined to what extent the number of measurements of cardiometabolic risk factors (e.g., blood pressure, cholesterol, HbA1c) were impacted by the COVID-19 pandemic, and whether these have recovered to expected levels.
Citation details to follow
- View the analysis code used in NHS England's SDE for England
- View the phenotyping algorithms and codelists used in NHS England's SDE for England
This is a sub-project of project CCU008 approved by the CVD-COVID-UK / COVID-IMPACT Approvals & Oversight Board (sub-project: CCU008_01).
Licensed under the Apache License, Version 2.0 (the "License"); you may not use this software except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0. Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License.